Virpax Pharmaceuticals Inc. Gains 32.93%
Fri, Dec 13, 2024 at 07:08 PM
Virpax Pharmaceuticals Inc. (VRPX:NASDAQ) jumped higher at $0.4, a gain of 32.9%. On Fri, Dec 13, 2024, VRPX:NASDAQ hit a New 2-Week Intraday High of $0.48. The stock got featured on our News Catalysts scanner on Fri, Nov 22, 2024 at 10:44 AM in the 'MISCELLANEOUS' category. From Fri, Nov 29, 2024, the stock recorded 10.00% Up Days and 36.36% Green Days
The stock spiked on Fri, Nov 22, 2024 at $1.05 with a volume of 160M+.
About Virpax Pharmaceuticals Inc. (VRPX:NASDAQ)
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management.
Top 10 Gainers:
- WISeKey International Holding AG (WKEY:NASDAQ), 139.02%
- MSP Recovery Inc. (LIFW:NASDAQ), 103.77%
- Innate Pharma S.A. (IPHA:NASDAQ), 96.1%
- Loop Industries, Inc. (LOOP:NASDAQ), 48.78%
- Direxion Daily AVGO Bull 2X Shares (AVL:NASDAQ), 48.47%
- Safe Pro Group Inc. (SPAI:NASDAQ), 37.65%
- Creative Global Technology Holdings Ltd. (CGTL:NASDAQ), 36.54%
- Virpax Pharmaceuticals Inc. (VRPX:NASDAQ), 32.93%
- TruGolf Inc Cl A (TRUG:NASDAQ), 31.84%
- SenesTech, Inc. (SNES:NASDAQ), 31.33%